Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

Frigault, MJ; Dietrich, J; Martinez-Lage, M; Leick, M; Choi, BD; DeFilipp, Z; Chen, YB; Abramson, J; Crombie, J; Armand, P; Nayak, L; Panzini, C; Riley, LS; Gallagher, K; Maus, MV

Frigault, MJ (reprint author), Massachusetts Gen Hosp, Canc Ctr, Zero Emerson Pl,Suite 118,Off 127, Boston, MA 02114 USA.

BLOOD, 2019; 134 (11): 860

Abstract

Chimeric antigen receptor (CAR) T cells targeting CD19 have emerged as a leading engineered T-cell therapy for relapsed/refractory B-cell non-Hodgkin ......

Full Text Link